These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17998714)

  • 1. Implications of p53 over-expression in the outcome with radiation in head and neck cancers.
    Lal P; Pal L; Kumar S; Dimri K; Tiwari A; Rastogi N; Singh S; Datta NR
    J Cancer Res Ther; 2007; 3(1):17-22. PubMed ID: 17998714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer.
    Grabenbauer GG; Steininger H; Meyer M; Fietkau R; Brunner T; Heinkelmann P; Hornung J; Iro H; Spitzer W; Kirchner T; Sauer R; Distel L
    Radiother Oncol; 1998 May; 47(2):175-83. PubMed ID: 9683366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
    Gasparini G; Bevilacqua P; Bonoldi E; Testolin A; Galassi A; Verderio P; Boracchi P; Guglielmi RB; Pezzella F
    Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of mutant-type p53 expression in squamous cell carcinoma of the head and neck during radiation therapy and its clinical significance: comparison of an immunohistochemical method and PCR-SSCP assay.
    Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
    Oncol Rep; 1998; 5(5):1053-9. PubMed ID: 9683807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.
    Homann N; Nees M; Conradt C; Dietz A; Weidauer H; Maier H; Bosch FX
    Clin Cancer Res; 2001 Feb; 7(2):290-6. PubMed ID: 11234882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy.
    Giatromanolaki A; Koukourakis M; Zaramboukas T; Skordalaki A; Arapantoni P; Georgoulias V; Fountzilas G
    Anticancer Res; 1998; 18(6B):4685-92. PubMed ID: 9891541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of p53 overexpression in head and neck carcinomas: a pilot study.
    Ghoshal S; Dey P; Saikia UN; Sharma SC
    Anal Quant Cytol Histol; 2002 Oct; 24(5):254-6. PubMed ID: 12408557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological tailoring of adjuvant radiotherapy in head and neck and oral malignancies - The potential role of p53 and eIF4E as predictive parameters.
    Joseph B; Kumar RV; Champaka G; Shenoy A; Sabitha KS; Lokesh V; Ramesh C; Vijay CR
    Indian J Cancer; 2019; 56(4):330-334. PubMed ID: 31607702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.
    Kuhnt T; Mueller AC; Pelz T; Haensgen G; Bloching M; Koesling S; Schubert J; Dunst J
    J Cancer Res Clin Oncol; 2005 Nov; 131(11):758-64. PubMed ID: 16088405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance.
    Riva C; Lavieille JP; Reyt E; Brambilla E; Lunardi J; Brambilla C
    Eur J Cancer B Oral Oncol; 1995 Nov; 31B(6):384-91. PubMed ID: 8746269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
    Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
    Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
    Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
    Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy.
    Pai HH; Rochon L; Clark B; Black M; Shenouda G
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):37-42. PubMed ID: 9588915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study.
    Raybaud-Diogène H; Fortin A; Morency R; Roy J; Monteil RA; Têtu B
    J Clin Oncol; 1997 Mar; 15(3):1030-8. PubMed ID: 9060543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer.
    Sauter ER; Ridge JA; Litwin S; Langer CJ
    Clin Cancer Res; 1995 Nov; 1(11):1407-12. PubMed ID: 9815938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of p53 and bcl-2 on proliferative activity and treatment outcome in head and neck cancer patients.
    Dijkema IM; Struikmans H; Dullens HF; Kal HB; van der Tweel I; Battermann JJ
    Oral Oncol; 2000 Jan; 36(1):54-60. PubMed ID: 10889920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.
    Shin DM; Lee JS; Lippman SM; Lee JJ; Tu ZN; Choi G; Heyne K; Shin HJ; Ro JY; Goepfert H; Hong WK; Hittelman WN
    J Natl Cancer Inst; 1996 Apr; 88(8):519-29. PubMed ID: 8606380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of p53 functional activity in tumor cells and histologically normal mucosa from patients with head and neck squamous cell carcinoma.
    Van der Vorst S; Dekairelle AF; Weynand B; Hamoir M; Gala JL
    Head Neck; 2012 Nov; 34(11):1542-50. PubMed ID: 22109999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.